| |||||||
|
|
Gain in-depth analysis on the avian
flu market and future of the antivirals market as a whole, product pipelines and
major players with Business Insights’ latest antivirals report...
The Antivirals Market Outlook:
Market analysis of future growth and leading players by sector.
Business Insights have teamed up with IMS Health to bring you, ‘The Antivirals Market Outlook: Market analysis of future growth and leading players by sector.’ This unique product offering provides an analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data, an unrivalled source of pharmaceutical intelligence on the Antivirals market. 'The Antivirals Market Outlook: Market analysis of future growth and leading players by sector', analyzes the market development in the US and the five major European markets. The major therapy areas covered in this report are: HIV, hepatitis, herpes, influenza, RSV and HPV. For each market therapy area there is a country-by-country analysis, a review of leading companies and an analysis of key brands allowing you to assess the best pipeline areas to invest in. Identify unmet needs and growth opportunities in each market by reviewing pipeline drugs with the most potential for profit for your company. Published: January 2005
http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_Business_Insight_2004.html#a976
The Vaccines Market Outlook: Market analysis of future growth and leading players by sector. Report Description:
Business Insights have teamed up with IMS Health to bring you, ‘The Vaccines Market Outlook: Market analysis of future growth and leading players by sector.’ This unique report provides unrivalled analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data, and also includes company reported sales data allowing you to spot any discrepancies between the two sets of data. Refresh your vaccines strategy with unrivalled analysis The Vaccines Market Outlook: Market analysis of future growth and leading players by sector provides a detailed analysis of the vaccines market in the US and the five major European markets. The market for vaccines is broken down by population (pediatric and adult) and also by disease area. A comprehensive competitive overview is provided with an examination of key brands together with profiles of the leading players in this market. This new report also reviews some of the most promising products in development, highlighting those expected to drive market growth in the future and in some cases become the first vaccine to market for a disease. Adult and travel vaccine segments are likely to drive growth in the future, use this latest vaccines report to discover the latest products which are set to transform this market. Published January 2005
http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_Business_Insight_2004.html#a978
You can also order on line at: http://www.bioportfolio.com/cgi-bin/acatalog/search.html |
|
| ||||||||